Recce Pharmaceuticals: A “superbug” killer
Listen to ASX-listed Recce Pharmaceuticals Managing Director, James Graham talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s new “superbug” destroying anti-infective synthetic drugs designed to kill antibiotic-resistant bugs.